Thrombocytopenia and prospective endovascular intervention in a patient with coronary artery disease

by A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin
Published 2019-01-01

Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding

by A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin
Published 2019-01-01

Difficulties in evaluating the efficacy of antiplatelet therapy in clinical practice

by L I Buryachkovskaya, I A Uchitel', A B Sumarokov, E G Popov, L I Buryachkovskaya, I A Uchitel, A B Sumarokov, E G Popov
Published 2009-05-01

A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Di...

by N. V. Lomakin, L. I. Buryachkovskaya, D. A. Zolin, V. I. Kazey
Published 2020-07-01

Clinical Significance of Thrombin Blockade with Low Doses (2.5 mg) of Rivaroxaban in Ischemic Heart Disease Patients

by A. B. Sumarokov, L. I. Buryachkovskaya, Y. V. Docenko, M. S. Kurochkin, N. V. Lomakin
Published 2020-03-01

Anti-aggregant therapy in patients with coronary heart disease and gastric ulcer

by A. B. Sumarokov, L. I. Buryachkovskaya, M. V. Ezhov, I. A. Uchitel’, Yu. V. Dotsenko
Published 2010-10-01

Platelet activation and red blood cell changes in thrombotic and rheological disturbances among coronary heart disease patients

by T. E. Shirokova, L. I. Buryachkovskaya, A. B. Sumarokov, I. A. Uchitel, E. G. Popov, A. V. Vavaev
Published 2007-10-01